Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

• Status: Unknown status
• Trial end date: 2016-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The use of propofol or dexmedetomedine for prevention of sevofurane emergence agitation in LDLT recipients

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AlRefaey Kandeel
• Treatments: Propofol

Criteria

Inclusion Criteria:

• All recipients of living donor liver transplantation

Exclusion Criteria:

• patient refusal Allergy to either propofol or dexmedetomediene CNS disease